Screening of Glypican-6 Expression in Benign, Primary and Metastatic Colon Cancers.

Additionally, a similar differential of glypican-6 expression was observed between benign tumour samples and primary tumour samples, although this finding did not reach statistical significance ( P = 0.155) ( Figure 2 ).

also in 111,027 other papers